Skip to content Skip to footer
RxDB
RxDB
Close
Kyprolis: Benefits, Reviews, Info, Side Effects!
Rx Details
Kyprolis
Carfilzomib, PR-171
Carfilzomib
2012
Prescription
Chemotherapy
Drugs
Prescription Only
Available
Increased progression-free survival, improved overall response rate, potential for deeper and more durable responses, used in combination with other therapies for multiple myeloma, generally well-tolerated with manageable side effects.
Anemia, Arthralgia, Back Pain, Constipation, Cough, Decreased Appetite, Diarrhea, Dyspnea, Edema, Fatigue, Fever, Headache, Hypertension, Hypokalemia, Insomnia, Muscle Spasms, Nausea, Thrombocytopenia, Upper Respiratory Tract Infection, Vomiting
Kyprolis (carfilzomib) is a medication used primarily in the treatment of multiple myeloma. The dosage of Kyprolis can vary based on several factors, including the specific treatment regimen, the patient’s body surface area, and their overall health condition. Typically, Kyprolis is administered intravenously, and the dosage is often calculated based on the patient’s body surface area (BSA) in square meters (m²). A common dosing schedule might involve administering Kyprolis at a dose of 20 mg/m² on the first day of treatment, followed by 27 mg/m² or 56 mg/m² on subsequent treatment days, depending on the specific regimen and patient tolerance. It’s important to note that the exact dosage and schedule should be determined by a healthcare professional, taking into account the individual patient’s needs and response to treatment. Always consult with a healthcare provider for precise dosing information tailored to a specific medical condition.
Multiple myeloma
Kyprolis has a moderate safety profile.
No Interactions Reported
$1,000 – $2,000
$10,000

A Synopsis of

Kyprolis

Kyprolis is a medication that is commonly used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This drug belongs to a class of medications known as proteasome inhibitors, which work by blocking the action of proteasomes, enzymes that break down proteins in cells.

Kyprolis is typically used in combination with other medications to help slow down the growth and spread of cancer cells. It is administered intravenously, usually once or twice a week, under the supervision of a healthcare provider. The dosage and frequency of Kyprolis will vary depending on the individual patient’s condition and response to treatment.

As with any medication, Kyprolis may cause side effects. Common side effects of this drug may include nausea, vomiting, diarrhea, fatigue, and low blood cell counts. It is important to discuss any side effects or concerns with your healthcare provider to ensure proper management and support during treatment.

It is important to follow your healthcare provider’s instructions carefully while taking Kyprolis. This may include regular blood tests to monitor your response to treatment and adjust your dosage as needed. It is also important to report any new or worsening symptoms to your healthcare provider promptly.

Overall, Kyprolis can be an effective treatment option for individuals with multiple myeloma. By working closely with your healthcare team and following their guidance, you can help manage your condition and improve your quality of life.

What'd you think of this RX?

PAGE LAST UPDATED

  • Post Views: 1872